Cargando…

A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern

The urgent need for, but limited availability of, SARS-CoV-2 vaccines worldwide has led to widespread consideration of dose-sparing strategies. Here, we evaluate the SARS-CoV-2-specific antibody responses following BNT162b2 vaccination in 150 previously SARS-CoV-2-infected individuals from a populat...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Gils, Marit J., van Willigen, Hugo D.G., Wynberg, Elke, Han, Alvin X., van der Straten, Karlijn, Burger, Judith A., Poniman, Meliawati, Oomen, Melissa, Tejjani, Khadija, Bouhuijs, Joey H., Verveen, Anouk, Lebbink, Romy, Dijkstra, Maartje, Appelman, Brent, Lavell, A.H. Ayesha, Caniels, Tom G., Bontjer, Ilja, van Vught, Lonneke A., Vlaar, Alexander P.J., Sikkens, Jonne J., Bomers, Marije K., Russell, Colin A., Kootstra, Neeltje A., Sanders, Rogier W., Prins, Maria, de Bree, Godelieve J., de Jong, Menno D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668345/ https://www.ncbi.nlm.nih.gov/pubmed/35103254 http://dx.doi.org/10.1016/j.xcrm.2021.100486

Ejemplares similares

Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study
por: van Gils, Marit J., et al.
Publicado: (2022)

Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination
por: Appelman, Brent, et al.
Publicado: (2021)

Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination
por: Caniels, Tom G., et al.
Publicado: (2021)

Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron
por: van der Straten, Karlijn, et al.
Publicado: (2022)

Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
por: Grobben, Marloes, et al.
Publicado: (2021)

The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study
por: Wynberg, Elke, et al.
Publicado: (2022)

Recent infection with HCoV-OC43 may be associated with protection against SARS-CoV-2 infection
por: Lavell, A.H. Ayesha, et al.
Publicado: (2022)

A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern
por: Brinkkemper, Mitch, et al.
Publicado: (2021)

A SARS-CoV-2 Wuhan spike virosome vaccine induces superior neutralization breadth compared to one using the Beta spike
por: van der Velden, Yme U., et al.
Publicado: (2022)

Why not to pick your nose: Association between nose picking and SARS-CoV-2 incidence, a cohort study in hospital health care workers
por: Lavell, A. H. Ayesha, et al.
Publicado: (2023)

Decreased Passive Immunity to Respiratory Viruses through Human Milk during the COVID-19 Pandemic
por: Grobben, Marloes, et al.
Publicado: (2022)

Discriminating cross-reactivity in polyclonal IgG1 responses against SARS-CoV-2 variants of concern
por: van Rijswijck, Danique M. H., et al.
Publicado: (2022)

Co-display of diverse spike proteins on nanoparticles broadens sarbecovirus neutralizing antibody responses
por: Brinkkemper, Mitch, et al.
Publicado: (2022)

Evolution of Coronavirus Disease 2019 (COVID-19) Symptoms During the First 12 Months After Illness Onset
por: Wynberg, Elke, et al.
Publicado: (2021)

Broad SARS-CoV-2 neutralization by monoclonal and bispecific antibodies derived from a Gamma-infected individual
por: Guerra, Denise, et al.
Publicado: (2023)

Health-related quality of life among persons with initial mild, moderate, and severe or critical COVID-19 at 1 and 12 months after infection: a prospective cohort study
por: Verveen, Anouk, et al.
Publicado: (2022)

Two‐year trajectories of COVID‐19 symptoms and their association with illness perception: A prospective cohort study in Amsterdam, the Netherlands
por: Wynberg, Elke, et al.
Publicado: (2023)

Severe Fatigue in the First Year Following SARS-CoV-2 Infection: A Prospective Cohort Study
por: Verveen, Anouk, et al.
Publicado: (2022)

A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike
por: Claireaux, Mathieu, et al.
Publicado: (2022)

Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses
por: Radić, Laura, et al.
Publicado: (2023)

E-learning on antibiotic prescribing—the role of autonomous motivation in participation: a prospective cohort study
por: Caris, Martine G, et al.
Publicado: (2018)

Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions
por: Schriek, Angela I., et al.
Publicado: (2022)

Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions
por: Schriek, Angela I., et al.
Publicado: (2022)

One-fourth of COVID-19 patients have an impaired pulmonary function after 12 months of disease onset
por: van Willigen, Hugo D. G., et al.
Publicado: (2023)

Inflammatory biomarkers at hospital discharge are associated with readmission and death in patients hospitalized for COVID-19
por: Slim, Marleen A., et al.
Publicado: (2021)

Prolonged indoleamine 2,3-dioxygenase-2 activity and associated cellular stress in post-acute sequelae of SARS-CoV-2 infection
por: Guo, Lihui, et al.
Publicado: (2023)

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
por: Brouwer, Philip J. M., et al.
Publicado: (2020)

Crosstalk between TLR8 and RIG-I-like receptors enhances antiviral immune responses
por: Vlaming, Killian E., et al.
Publicado: (2023)

Stay Tuned: What Is Special About Not Shifting Attention?
por: Talsma, Durk, et al.
Publicado: (2011)

The Hepatitis B Virus X Protein Inhibits Thymine DNA Glycosylase Initiated Base Excision Repair
por: van de Klundert, Maarten A. A., et al.
Publicado: (2012)

Comparison of hospital treatment strategy or of treatment actually received in COVID-19?: Commenting on: Lammers AJJ, Brohet RM, Theunissen REP, Koster C, Rood R, Verhagen DWM, et al. Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients. Int J Infect Dis. 2020 September
por: Sikkens, Jonne J., et al.
Publicado: (2021)

Polymorphisms in the Regulatory Region of the Cyclophilin A Gene Influence the Susceptibility for HIV-1 Infection
por: Rits, Maarten A. N., et al.
Publicado: (2008)

Serologic Surveillance and Phylogenetic Analysis of SARS-CoV-2 Infection Among Hospital Health Care Workers
por: Sikkens, Jonne J., et al.
Publicado: (2021)

Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV
por: Verburgh, Myrthe L., et al.
Publicado: (2023)

Hepatitis B Virus Protein X Induces Degradation of Talin-1
por: van de Klundert, Maarten A. A., et al.
Publicado: (2016)

Phosphodiesterase 8a Supports HIV-1 Replication in Macrophages at the Level of Reverse Transcription
por: Booiman, Thijs, et al.
Publicado: (2014)

DYRK1A Controls HIV-1 Replication at a Transcriptional Level in an NFAT Dependent Manner
por: Booiman, Thijs, et al.
Publicado: (2015)

Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acute HIV infection
por: van Paassen, Pien M., et al.
Publicado: (2023)

Optimization of Anti-SARS-CoV-2 Neutralizing Antibody Therapies: Roadmap to Improve Clinical Effectiveness and Implementation
por: van der Straten, Karlijn, et al.
Publicado: (2022)

Protein X of Hepatitis B Virus: Origin and Structure Similarity with the Central Domain of DNA Glycosylase
por: van Hemert, Formijn J., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_lov5cvrfpbh4lip1bjhshm38mg